Related Experiment Video
Updated: Dec 11, 2025

08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.4K
Anakinra for patients with COVID-19 - Authors' reply
Giulio Cavalli1, Giovanni Landoni2, Alberto Zangrillo3
1Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan 20132, Italy.
The Lancet. Rheumatology
|August 25, 2020
Summary
No abstract available in PubMed .

